Navigation Links
Non-Randomized, Multi-Center US Clinical Trial of the GORE ACUSEAL Vascular Graft Presented at VEITHsymposium in New York
Date:11/19/2013

NEW YORK, Nov. 19, 2013 /PRNewswire-iReach/ -- Principal investigator, Dr. Marc Glickman, chief of Vascular Services for Sentara Healthcare, (Norfolk, VA) announced today at the 40th Annual VEITHsymposium held at the Hilton New York Midtown, 1335 Avenue of the Americas (New York, NY), the results of early cannulation of the GORE ACUSEAL vascular graft for vascular access.  Glickman emphasized that the vascular graft design expands treatment options for earlier removal or possible avoidance of a central venous catheter (a major source of infection for hemodialysis patients). 

Glickman reported, "Early cannulation is made possible by the unique tri-layer design of the GORE ACUSEAL Vascular Graft, featuring a low-bleed elastomeric middle membrane between inner and outer layers of expanded polytetrafluoroethylene (ePTFE). This middle membrane hinders suture line and cannulation needle bleeding and may reduce the risk of seroma formation and pseudoaneurysm. The design is kink resistant and flexible at curves while allowing for precise suturing and anastomotic tailoring."                                             

The recently completed prospective, non-randomized, multi-center US clinical trial (138 subjects) demonstrated that the six-month cumulative patency of the GORE ACUSEAL Vascular Graft is comparable to that of other arteriovenous grafts with 84 percent patency compared to 75 percent patency in the historical control.  The results showed that within 28 days of graft implantation, 75.6 percent of the implanted GORE ACUSEAL Vascular Grafts had been s
'/>"/>

SOURCE VEITHsymposium
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
2. EarlySense System Implementation Shown to Reduce Falls, Decrease Transfers to Hospitals and Increase the Quality of Care for Elderly in Multi-Center Nursing Home Study
3. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
4. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
5. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
6. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
7. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
10. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
11. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015 HeartWare International, Inc . ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... President and Chief Executive Officer, Doug Godshall , ... Annual Growth Conference at 8:30 a.m. EDT on Thursday, ... 12-13, 2015 at the InterContinental Boston. A ...
(Date:8/4/2015)... , Aug. 4, 2015 Levi & Korsinsky ... ("Biogen" or the "Company") (NASDAQGS: BIIB) for possible violations ... and certain of its officers and/or directors have violated ... of 1934.  On Friday, July 24, 2015, prior to ... quarter 2015 financial results. Among other things, the Company ...
(Date:8/4/2015)... CARLSBAD, Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. ... $35.6 million and $18.9 million for the three and ... a net loss of $12.1 million and $43.4 million ... financial results were driven primarily by the more than ... quarter related to the upfront payment from Bayer to ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... overview at the Stifel Nicolaus Annual Healthcare Conference on Thursday, ... be held at the Four Seasons Hotel in Boston, MA. ... presentation will be available on the company,s website at ...
... (NASDAQ: STXS ) today announced that executive management ... held September 7-9, 2011 in Boston, MA.  Michael P. Kaminski, ... present an overview of the Company on Wednesday, September 7, ... webcast and subsequent archived replay of the presentation will be ...
Cached Medicine Technology:Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011 2Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... Healthy Origins® Cognizin® is a trademark for Citicoline, a nutrient that supports ... capsule for those applications which have more of a semi-solid composition. Vegetarian ...
(Date:8/4/2015)... ... 04, 2015 , ... It’s hard to look your best, ... in Santa Barbara, CA is offering the solution by offering an underarm sweat-removing ... and odor glands in the underarms. This simple and permanent solution usually offers ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent ... have shown a rise in binge drinking among certain populations and ... depression, are continuing to examine trends and evidence to help facilitate health care ...
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is worth ... conditions, pictures and medical art can be essential. StayWell, a health solutions company, announced ... Patient Education solutions have been used by physicians and other health care providers for ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... solutions, today announced that Bruce McCalley joins its executive leadership team as Senior ... of sales success at technology companies and expanding global markets with a special ...
Breaking Medicine News(10 mins):Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3
... time for cancer patients in Ontario for radiation has fallen, ... need//. These were the results of a study released by ... Ontario has reported that the system quality index launched last ... radiation treatment to 4.7 weeks, from seven weeks in 2002. ...
... study conducted by Dr. Martina Stippler it was found that ... brain injury//. A team at the University Of Pittsburgh Brain ... patients with severe brain injuries. The study results were presented ... Surgeons in San Francisco. ,The results show that ...
... has revealed the possibilities for the development of a ... well as reversible within a few months of discontinuing ... present are limited to condoms, vasectomy and withdrawal. ... either unreliable or as in the case of vasectomy, ...
... (FDA) has categorically ruled out endorsing the use of ... of Medicine report in 1999, which had said that ... conditions like AIDS wasting, chemotherapy induced nausea and vomiting ... statement issued on Thursday, the FDA stated that "no ...
... cancers that results in death among the Britons. This ... tablet// called Xeloda have only been given to NHS ... of Health and Clinical Excellence (NICE) issued guidance recommending ... had cancerous tissue removed at an early stage. Hence ...
... advice of central government, the Madhya Pradesh government banned ... by vets, saying that it was responsible// for 95 ... vultures are indispensable natural scavengers responsible for the disposal ... of epidemics. But when they themselves feed on animals ...
Cached Medicine News:Health News:Chemotherapy Queues in Ontario Stay Steady 2Health News:Male Contraceptives-Soon to be Reliable and Reversible 2
Cushing pituitary spoons, malleable copper, silver plated....
... Cougar is an Anterior Spinal Implant system. ... approximating that of cortical bone. The result ... requirements of anterior column support, while optimizing ... sharing design. Incorporates an anatomic design with ...
... Stackable Cage System provides anterior column support ... vertebrectomies from T1 to L5. The system ... Fiber Polymer cages that are stacked to ... The Peek Carbon Fiber Reinforced Polymer material ...
... Jaguar Lumbar I/F Cage system is a ... separate the mechanical and biologic functions of ... Lumbar I/F Cage provides a device designed ... and uses autologous cancellous bone, the best ...
Medicine Products: